Click for best price
Ipilimumab Market Size, Share 2023
The global Ipilimumab market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Ipilimumab market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Ipilimumab market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Ipilimumab market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Ipilimumab is a monoclonal antibody, more specifically a fully humanized IgG1 antibody produced in mammalian cell culture, to the cytotoxic T lymphocyte antigen-4 (CTLA-4) which activates antitumor immunity by inhibiting this major checkpoint.
This report aims to provide a comprehensive presentation of the global market for Ipilimumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ipilimumab.
This report contains market size and forecasts of Ipilimumab in global, including the following market information:
- Global Ipilimumab Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global Ipilimumab Market Sales, 2018-2023, 2024-2030, (KG)
- Global top five Ipilimumab companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
PD - L1 Antagonists Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ipilimumab include Gilead, BMS, Ono, Roche, Prestige BioPharma, Avacta, Baxter and Shenyang Sansheng Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ipilimumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ipilimumab Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (KG)
Global Ipilimumab Market Segment Percentages, by Type, 2022 (%)
- PD - L1 Antagonists
- CTLA4 Antagonists
- Immunocheckpoint Inhibitors
- Other
Global Ipilimumab Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (KG)
Global Ipilimumab Market Segment Percentages, by Application, 2022 (%)
Global Ipilimumab Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (KG)
Global Ipilimumab Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Ipilimumab revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Ipilimumab revenues share in global market, 2022 (%)
- Key companies Ipilimumab sales in global market, 2018-2023 (Estimated), (KG)
- Key companies Ipilimumab sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Gilead
- BMS
- Ono
- Roche
- Prestige BioPharma
- Avacta
- Baxter
- Shenyang Sansheng Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ipilimumab, market overview.
Chapter 2: Global Ipilimumab market size in revenue and volume.
Chapter 3: Detailed analysis of Ipilimumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ipilimumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ipilimumab capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Ipilimumab Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ipilimumab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ipilimumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ipilimumab Overall Market Size
2.1 Global Ipilimumab Market Size: 2022 VS 2030
2.2 Global Ipilimumab Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Ipilimumab Sales: 2018-2030
3 Company Landscape
3.1 Top Ipilimumab Players in Global Market
3.2 Top Global Ipilimumab Companies Ranked by Revenue
3.3 Global Ipilimumab Revenue by Companies
3.4 Global Ipilimumab Sales by Companies
3.5 Global Ipilimumab Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ipilimumab Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ipilimumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ipilimumab Players in Global Market
3.8.1 List of Global Tier 1 Ipilimumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Ipilimumab Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Ipilimumab Market Size Markets, 2022 & 2030
4.1.2 PD - L1 Antagonists
4.1.3 CTLA4 Antagonists
4.1.4 Immunocheckpoint Inhibitors
4.1.5 Other
4.2 By Type - Global Ipilimumab Revenue & Forecasts
4.2.1 By Type - Global Ipilimumab Revenue, 2018-2023
4.2.2 By Type - Global Ipilimumab Revenue, 2024-2030
4.2.3 By Type - Global Ipilimumab Revenue Market Share, 2018-2030
4.3 By Type - Global Ipilimumab Sales & Forecasts
4.3.1 By Type - Global Ipilimumab Sales, 2018-2023
4.3.2 By Type - Global Ipilimumab Sales, 2024-2030
4.3.3 By Type - Global Ipilimumab Sales Market Share, 2018-2030
4.4 By Type - Global Ipilimumab Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ipilimumab Market Size, 2022 & 2030
5.1.2 Cancer
5.1.3 Melanoma
5.2 By Application - Global Ipilimumab Revenue & Forecasts
5.2.1 By Application - Global Ipilimumab Revenue, 2018-2023
5.2.2 By Application - Global Ipilimumab Revenue, 2024-2030
5.2.3 By Application - Global Ipilimumab Revenue Market Share, 2018-2030
5.3 By Application - Global Ipilimumab Sales & Forecasts
5.3.1 By Application - Global Ipilimumab Sales, 2018-2023
5.3.2 By Application - Global Ipilimumab Sales, 2024-2030
5.3.3 By Application - Global Ipilimumab Sales Market Share, 2018-2030
5.4 By Application - Global Ipilimumab Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Ipilimumab Market Size, 2022 & 2030
6.2 By Region - Global Ipilimumab Revenue & Forecasts
6.2.1 By Region - Global Ipilimumab Revenue, 2018-2023
6.2.2 By Region - Global Ipilimumab Revenue, 2024-2030
6.2.3 By Region - Global Ipilimumab Revenue Market Share, 2018-2030
6.3 By Region - Global Ipilimumab Sales & Forecasts
6.3.1 By Region - Global Ipilimumab Sales, 2018-2023
6.3.2 By Region - Global Ipilimumab Sales, 2024-2030
6.3.3 By Region - Global Ipilimumab Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Ipilimumab Revenue, 2018-2030
6.4.2 By Country - North America Ipilimumab Sales, 2018-2030
6.4.3 US Ipilimumab Market Size, 2018-2030
6.4.4 Canada Ipilimumab Market Size, 2018-2030
6.4.5 Mexico Ipilimumab Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Ipilimumab Revenue, 2018-2030
6.5.2 By Country - Europe Ipilimumab Sales, 2018-2030
6.5.3 Germany Ipilimumab Market Size, 2018-2030
6.5.4 France Ipilimumab Market Size, 2018-2030
6.5.5 U.K. Ipilimumab Market Size, 2018-2030
6.5.6 Italy Ipilimumab Market Size, 2018-2030
6.5.7 Russia Ipilimumab Market Size, 2018-2030
6.5.8 Nordic Countries Ipilimumab Market Size, 2018-2030
6.5.9 Benelux Ipilimumab Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Ipilimumab Revenue, 2018-2030
6.6.2 By Region - Asia Ipilimumab Sales, 2018-2030
6.6.3 China Ipilimumab Market Size, 2018-2030
6.6.4 Japan Ipilimumab Market Size, 2018-2030
6.6.5 South Korea Ipilimumab Market Size, 2018-2030
6.6.6 Southeast Asia Ipilimumab Market Size, 2018-2030
6.6.7 India Ipilimumab Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Ipilimumab Revenue, 2018-2030
6.7.2 By Country - South America Ipilimumab Sales, 2018-2030
6.7.3 Brazil Ipilimumab Market Size, 2018-2030
6.7.4 Argentina Ipilimumab Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ipilimumab Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Ipilimumab Sales, 2018-2030
6.8.3 Turkey Ipilimumab Market Size, 2018-2030
6.8.4 Israel Ipilimumab Market Size, 2018-2030
6.8.5 Saudi Arabia Ipilimumab Market Size, 2018-2030
6.8.6 UAE Ipilimumab Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Gilead
7.1.1 Gilead Company Summary
7.1.2 Gilead Business Overview
7.1.3 Gilead Ipilimumab Major Product Offerings
7.1.4 Gilead Ipilimumab Sales and Revenue in Global (2018-2023)
7.1.5 Gilead Key News & Latest Developments
7.2 BMS
7.2.1 BMS Company Summary
7.2.2 BMS Business Overview
7.2.3 BMS Ipilimumab Major Product Offerings
7.2.4 BMS Ipilimumab Sales and Revenue in Global (2018-2023)
7.2.5 BMS Key News & Latest Developments
7.3 Ono
7.3.1 Ono Company Summary
7.3.2 Ono Business Overview
7.3.3 Ono Ipilimumab Major Product Offerings
7.3.4 Ono Ipilimumab Sales and Revenue in Global (2018-2023)
7.3.5 Ono Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Ipilimumab Major Product Offerings
7.4.4 Roche Ipilimumab Sales and Revenue in Global (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Prestige BioPharma
7.5.1 Prestige BioPharma Company Summary
7.5.2 Prestige BioPharma Business Overview
7.5.3 Prestige BioPharma Ipilimumab Major Product Offerings
7.5.4 Prestige BioPharma Ipilimumab Sales and Revenue in Global (2018-2023)
7.5.5 Prestige BioPharma Key News & Latest Developments
7.6 Avacta
7.6.1 Avacta Company Summary
7.6.2 Avacta Business Overview
7.6.3 Avacta Ipilimumab Major Product Offerings
7.6.4 Avacta Ipilimumab Sales and Revenue in Global (2018-2023)
7.6.5 Avacta Key News & Latest Developments
7.7 Baxter
7.7.1 Baxter Company Summary
7.7.2 Baxter Business Overview
7.7.3 Baxter Ipilimumab Major Product Offerings
7.7.4 Baxter Ipilimumab Sales and Revenue in Global (2018-2023)
7.7.5 Baxter Key News & Latest Developments
7.8 Shenyang Sansheng Pharmaceutical
7.8.1 Shenyang Sansheng Pharmaceutical Company Summary
7.8.2 Shenyang Sansheng Pharmaceutical Business Overview
7.8.3 Shenyang Sansheng Pharmaceutical Ipilimumab Major Product Offerings
7.8.4 Shenyang Sansheng Pharmaceutical Ipilimumab Sales and Revenue in Global (2018-2023)
7.8.5 Shenyang Sansheng Pharmaceutical Key News & Latest Developments
8 Global Ipilimumab Production Capacity, Analysis
8.1 Global Ipilimumab Production Capacity, 2018-2030
8.2 Ipilimumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Ipilimumab Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ipilimumab Supply Chain Analysis
10.1 Ipilimumab Industry Value Chain
10.2 Ipilimumab Upstream Market
10.3 Ipilimumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ipilimumab Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Ipilimumab in Global Market
Table 2. Top Ipilimumab Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Ipilimumab Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Ipilimumab Revenue Share by Companies, 2018-2023
Table 5. Global Ipilimumab Sales by Companies, (KG), 2018-2023
Table 6. Global Ipilimumab Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Ipilimumab Price (2018-2023) & (US$/G)
Table 8. Global Manufacturers Ipilimumab Product Type
Table 9. List of Global Tier 1 Ipilimumab Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ipilimumab Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Ipilimumab Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Ipilimumab Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Ipilimumab Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Ipilimumab Sales (KG), 2018-2023
Table 15. By Type - Global Ipilimumab Sales (KG), 2024-2030
Table 16. By Application ? Global Ipilimumab Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Ipilimumab Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Ipilimumab Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Ipilimumab Sales (KG), 2018-2023
Table 20. By Application - Global Ipilimumab Sales (KG), 2024-2030
Table 21. By Region ? Global Ipilimumab Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Ipilimumab Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Ipilimumab Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Ipilimumab Sales (KG), 2018-2023
Table 25. By Region - Global Ipilimumab Sales (KG), 2024-2030
Table 26. By Country - North America Ipilimumab Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Ipilimumab Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Ipilimumab Sales, (KG), 2018-2023
Table 29. By Country - North America Ipilimumab Sales, (KG), 2024-2030
Table 30. By Country - Europe Ipilimumab Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Ipilimumab Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Ipilimumab Sales, (KG), 2018-2023
Table 33. By Country - Europe Ipilimumab Sales, (KG), 2024-2030
Table 34. By Region - Asia Ipilimumab Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Ipilimumab Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Ipilimumab Sales, (KG), 2018-2023
Table 37. By Region - Asia Ipilimumab Sales, (KG), 2024-2030
Table 38. By Country - South America Ipilimumab Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Ipilimumab Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Ipilimumab Sales, (KG), 2018-2023
Table 41. By Country - South America Ipilimumab Sales, (KG), 2024-2030
Table 42. By Country - Middle East & Africa Ipilimumab Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Ipilimumab Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Ipilimumab Sales, (KG), 2018-2023
Table 45. By Country - Middle East & Africa Ipilimumab Sales, (KG), 2024-2030
Table 46. Gilead Company Summary
Table 47. Gilead Ipilimumab Product Offerings
Table 48. Gilead Ipilimumab Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 49. Gilead Key News & Latest Developments
Table 50. BMS Company Summary
Table 51. BMS Ipilimumab Product Offerings
Table 52. BMS Ipilimumab Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 53. BMS Key News & Latest Developments
Table 54. Ono Company Summary
Table 55. Ono Ipilimumab Product Offerings
Table 56. Ono Ipilimumab Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 57. Ono Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche Ipilimumab Product Offerings
Table 60. Roche Ipilimumab Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 61. Roche Key News & Latest Developments
Table 62. Prestige BioPharma Company Summary
Table 63. Prestige BioPharma Ipilimumab Product Offerings
Table 64. Prestige BioPharma Ipilimumab Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 65. Prestige BioPharma Key News & Latest Developments
Table 66. Avacta Company Summary
Table 67. Avacta Ipilimumab Product Offerings
Table 68. Avacta Ipilimumab Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 69. Avacta Key News & Latest Developments
Table 70. Baxter Company Summary
Table 71. Baxter Ipilimumab Product Offerings
Table 72. Baxter Ipilimumab Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 73. Baxter Key News & Latest Developments
Table 74. Shenyang Sansheng Pharmaceutical Company Summary
Table 75. Shenyang Sansheng Pharmaceutical Ipilimumab Product Offerings
Table 76. Shenyang Sansheng Pharmaceutical Ipilimumab Sales (KG), Revenue (US$, Mn) and Average Price (US$/G) (2018-2023)
Table 77. Shenyang Sansheng Pharmaceutical Key News & Latest Developments
Table 78. Ipilimumab Production Capacity (KG) of Key Manufacturers in Global Market, 2021-2023 (KG)
Table 79. Global Ipilimumab Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Ipilimumab Production by Region, 2018-2023 (KG)
Table 81. Global Ipilimumab Production by Region, 2024-2030 (KG)
Table 82. Ipilimumab Market Opportunities & Trends in Global Market
Table 83. Ipilimumab Market Drivers in Global Market
Table 84. Ipilimumab Market Restraints in Global Market
Table 85. Ipilimumab Raw Materials
Table 86. Ipilimumab Raw Materials Suppliers in Global Market
Table 87. Typical Ipilimumab Downstream
Table 88. Ipilimumab Downstream Clients in Global Market
Table 89. Ipilimumab Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ipilimumab Segment by Type in 2022
Figure 2. Ipilimumab Segment by Application in 2022
Figure 3. Global Ipilimumab Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ipilimumab Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Ipilimumab Revenue, 2018-2030 (US$, Mn)
Figure 7. Ipilimumab Sales in Global Market: 2018-2030 (KG)
Figure 8. The Top 3 and 5 Players Market Share by Ipilimumab Revenue in 2022
Figure 9. By Type - Global Ipilimumab Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Ipilimumab Revenue Market Share, 2018-2030
Figure 11. By Type - Global Ipilimumab Sales Market Share, 2018-2030
Figure 12. By Type - Global Ipilimumab Price (US$/G), 2018-2030
Figure 13. By Application - Global Ipilimumab Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Ipilimumab Revenue Market Share, 2018-2030
Figure 15. By Application - Global Ipilimumab Sales Market Share, 2018-2030
Figure 16. By Application - Global Ipilimumab Price (US$/G), 2018-2030
Figure 17. By Region - Global Ipilimumab Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Ipilimumab Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Ipilimumab Revenue Market Share, 2018-2030
Figure 20. By Region - Global Ipilimumab Sales Market Share, 2018-2030
Figure 21. By Country - North America Ipilimumab Revenue Market Share, 2018-2030
Figure 22. By Country - North America Ipilimumab Sales Market Share, 2018-2030
Figure 23. US Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Ipilimumab Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Ipilimumab Sales Market Share, 2018-2030
Figure 28. Germany Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 29. France Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Ipilimumab Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Ipilimumab Sales Market Share, 2018-2030
Figure 37. China Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 41. India Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Ipilimumab Revenue Market Share, 2018-2030
Figure 43. By Country - South America Ipilimumab Sales Market Share, 2018-2030
Figure 44. Brazil Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Ipilimumab Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Ipilimumab Sales Market Share, 2018-2030
Figure 48. Turkey Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Ipilimumab Revenue, (US$, Mn), 2018-2030
Figure 52. Global Ipilimumab Production Capacity (KG), 2018-2030
Figure 53. The Percentage of Production Ipilimumab by Region, 2022 VS 2030
Figure 54. Ipilimumab Industry Value Chain
Figure 55. Marketing Channels
